o-desmethylindomethacin has been researched along with norbinaltorphimine in 1 studies
| Studies (o-desmethylindomethacin) | Trials (o-desmethylindomethacin) | Recent Studies (post-2010) (o-desmethylindomethacin) | Studies (norbinaltorphimine) | Trials (norbinaltorphimine) | Recent Studies (post-2010) (norbinaltorphimine) |
|---|---|---|---|---|---|
| 27 | 0 | 4 | 918 | 0 | 205 |
| Protein | Taxonomy | o-desmethylindomethacin (IC50) | norbinaltorphimine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0104 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0029 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.212 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.024 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallo, RV; Zhen, S | 1 |
1 other study(ies) available for o-desmethylindomethacin and norbinaltorphimine
| Article | Year |
|---|---|
The role of norepinephrine in mediating luteinizing hormone release in response to blockade of kappa-opioid receptors in the medial preoptic area.
Topics: Animals; Basal Metabolism; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Female; Indomethacin; Luteinizing Hormone; Naltrexone; Norepinephrine; Preoptic Area; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Secretory Rate | 1995 |